Menu Search
Equities

Wanjia Group Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
401:HKG.HZ

Wanjia Group Holdings Ltd

Actions
  • Price (HKD)0.12
  • Today's Change0.00 / 0.00%
  • Shares traded22.56k
  • 1 Year change+92.96%
  • Beta0.7956
Data delayed at least 15 minutes, as of Feb 16 2026 02:14 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Wanjia Group Holdings Ltd is an investment holding company principally engaged in the pharmaceutical wholesale and distribution business, and hemodialysis treatment and consultancy service business. The Company mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.

  • Revenue in HKD (TTM)163.70m
  • Net income in HKD-8.58m
  • Incorporated2012
  • Employees177.00
  • Location
    Wanjia Group Holdings LtdRoom 190219/F, No. 101 King's Road, North Point Hong KongHKG
  • Phone+852 23663375
  • Fax+852 27239025
  • Websitehttps://www.wanjia-gp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.